The FY26 after-tax result was a $3.09 million loss, compared with a $7.55 million profit in FY25, following a 5.26% decline in the investment portfolio — a steeper fall than the -4.49% recorded by the S&P/ASX 300 Industrials Accumulationindexbenchmark. This followed a much stronger …
Construction completion at Mardie reached 85% at 30 June 2026, up from 69% a year earlier. The project produced its first crystallised salt during FY26, with 49,000 tonnes recorded by year-end as the brine circuit operated through the evaporation ponds and initial crystallisers.
Revenue fell 6.7% to $88.9 million, affected by higher Student Visa Application Charges and lower visa grant rates. Despite this, underlying EBITDA rose 7.0% to $15.3 million, helped by grossMarginimproving to 55.4% from 53.6% and operating costs falling to $33.9 million from $36.8 million.
Operating profit after tax for the year to 30 June 2026 reached $508 million, up from $474 million, with operating earnings per security rising to 12.9 cents from 12.0 cents. Statutory profit jumped to $677 million from $68 million, while net tangible assets rose …
Revenue for the year to 30 June 2026 increased 9.9% to $13.5 billion, with Underlying EBITDA up 5.0% to $614 million. However, Underlying NPAT declined 3.1% to $250 million as depreciation, amortisation and financing costs rose following the group's infrastructure investment program. Underlying EPS …
Mineral sands revenue for H1 2026 fell 22% to $433 million from $558 million, with underlying EBITDA down 81% to $41 million and the EBITDAMarginfalling to 9% from 39%. Group EBIT moved to a $10 million loss and NPAT to a $24 million loss.
Turners has maintained its $65 million FY27 NPBT target, though it says trading conditions in the first half of FY27 have become materially harder than the prior two years. Weaker consumer confidence and higher fuel prices have reduced demand for diesel and larger petrol-engine …
The trial's primary endpoint compared treatment cost per percentage of total body surface area (TBSA) treated. PermeaDerm recorded a mean cost of $148.70 per 1% TBSA, against $497.10 for allograft — a saving of roughly $348 per percentage point and a 70% lower product …
Rox and itsSubsidiaryRox (Murchison) Pty Ltd have signed a Native Title Mining Agreement with the Badimia Barna Native Title Claim Applicant. The agreement provides consent for future tenure grants, renewals and approvals across the Youanmi project area, covering both existing tenure and future applications.
KalGold has entered a comprehensive Heritage Protection Agreement with Kakarra Aboriginal Corporation RNTBC, covering Kakarra Country east of Kalgoorlie. The updated deal replaces an earlier arrangement limited to a single tenement and follows a Federal Court native title determination in April 2025.